[EN] USP7 BINDING SURVIVAL-TARGETING CHIMERIC (SURTAC) MOLECULES & USES THEREOF<br/>[FR] MOLÉCULES CHIMÉRIQUES CIBLANT LA SURVIE (SURTAC) SE LIANT À USP7 ET LEURS UTILISATIONS
申请人:LOCKI THERAPEUTICS LTD
公开号:WO2022148821A1
公开(公告)日:2022-07-14
Chimeric molecules that include a USP7 binding domain and uses thereof for deubiquitinating a ubiquitinylated protein, and or for treating a disease in a subject in need are provided herein. Further, Survival-Targeting Chimeric (SURTAC) molecules that include a USP7 binding domain linked to a target protein binding domain are disclosed herein, as are their uses for deubiquitination and treating disease. In some instances, the target protein is a ubiquitinylated protein, wherein a bound USP7 enzyme may proteolytically remove ubiquitin from the target ubiquitinylated protein.
本文提供了包含USP7结合域的嵌合分子及其用途,用于去泛素化泛素化蛋白质或治疗需要的主体的疾病。此外,本文还公开了包括USP7结合域连接到目标蛋白质结合域的Survival-Targeting Chimeric(SURTAC)分子及其用途,用于去泛素化和治疗疾病。在某些情况下,目标蛋白质是泛素化蛋白质,其中结合的USP7酶可以通过蛋白酶作用从目标泛素化蛋白质中去除泛素。